Notably, MUC16 expression stands out in NSCLC, significantly elevated compared to adjacent non-cancerous tissues, and tightly correlated with clinicopathological parameters like tumor staging, pathological grading, and lymph node involvement (64, 72). The gene discussed is MUC16; the disease is non-small cell lung carcinoma.